• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Mouse models of spinocerebellar ataxia type 3 (Machado-Joseph disease).脊髓小脑共济失调 3 型(马查多-约瑟夫病)的小鼠模型。
Neurotherapeutics. 2012 Apr;9(2):285-96. doi: 10.1007/s13311-012-0117-x.
2
Silencing mutant ataxin-3 rescues motor deficits and neuropathology in Machado-Joseph disease transgenic mice.沉默突变型共济失调-3 可挽救 Machado-Joseph 病转基因小鼠的运动缺陷和神经病理学。
PLoS One. 2013;8(1):e52396. doi: 10.1371/journal.pone.0052396. Epub 2013 Jan 22.
3
A mutant ataxin-3 putative-cleavage fragment in brains of Machado-Joseph disease patients and transgenic mice is cytotoxic above a critical concentration.在马查多-约瑟夫病患者和转基因小鼠大脑中,一种突变型ataxin-3推定裂解片段在超过临界浓度时具有细胞毒性。
J Neurosci. 2004 Nov 10;24(45):10266-79. doi: 10.1523/JNEUROSCI.2734-04.2004.
4
A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD.一个新的人源化 ataxin-3 敲入小鼠模型结合了 SCA3/MJD 的遗传特征、神经元和神经胶质的发病机制以及疾病的晚期发病。
Neurobiol Dis. 2015 Jan;73:174-88. doi: 10.1016/j.nbd.2014.09.020. Epub 2014 Oct 7.
5
Overexpression of mutant ataxin-3 in mouse cerebellum induces ataxia and cerebellar neuropathology.突变型共济失调 3 蛋白在小鼠小脑中的过表达可引起共济失调和小脑神经病理学改变。
Cerebellum. 2013 Aug;12(4):441-55. doi: 10.1007/s12311-012-0432-0.
6
A mutant ataxin-3 fragment results from processing at a site N-terminal to amino acid 190 in brain of Machado-Joseph disease-like transgenic mice.在马查多-约瑟夫病样转基因小鼠的大脑中,一种突变的ataxin-3片段是由在氨基酸190 N端的一个位点进行加工产生的。
Neurobiol Dis. 2007 Sep;27(3):362-9. doi: 10.1016/j.nbd.2007.06.005. Epub 2007 Jun 13.
7
The blood-brain barrier is disrupted in Machado-Joseph disease/spinocerebellar ataxia type 3: evidence from transgenic mice and human post-mortem samples.脑血屏障在 Machado-Joseph 病/脊髓小脑共济失调 3 型中被破坏:来自转基因小鼠和人类死后样本的证据。
Acta Neuropathol Commun. 2020 Aug 31;8(1):152. doi: 10.1186/s40478-020-00955-0.
8
Motor uncoordination and neuropathology in a transgenic mouse model of Machado-Joseph disease lacking intranuclear inclusions and ataxin-3 cleavage products.运动不协调和神经病理学在一个缺乏核内包涵体和 ataxin-3 切割产物的 Machado-Joseph 病转基因小鼠模型中。
Neurobiol Dis. 2010 Oct;40(1):163-76. doi: 10.1016/j.nbd.2010.05.021. Epub 2010 May 25.
9
RNA Interference Therapy for Machado-Joseph Disease: Long-Term Safety Profile of Lentiviral Vectors Encoding Short Hairpin RNAs Targeting Mutant Ataxin-3.肌萎缩性脊髓侧索硬化症的 RNA 干扰治疗:靶向突变 Ataxin-3 的短发夹 RNA 的慢病毒载体的长期安全性特征。
Hum Gene Ther. 2019 Jul;30(7):841-854. doi: 10.1089/hum.2018.157. Epub 2019 May 28.
10
Caffeine and adenosine A(2A) receptor inactivation decrease striatal neuropathology in a lentiviral-based model of Machado-Joseph disease.咖啡因和腺苷 A(2A)受体失活可减少基于慢病毒的 Machado-Joseph 病模型中的纹状体神经病理学。
Ann Neurol. 2013 May;73(5):655-66. doi: 10.1002/ana.23866. Epub 2013 Apr 26.

引用本文的文献

1
Exome sequencing identifies novel genes associated with cerebellar volume and microstructure.外显子组测序鉴定出与小脑体积和微观结构相关的新基因。
Commun Biol. 2025 Mar 1;8(1):344. doi: 10.1038/s42003-025-07797-3.
2
Slc9a6 mutation causes Purkinje cell loss and ataxia in the shaker rat.Slc9a6 突变导致 shake 大鼠浦肯野细胞丢失和共济失调。
Hum Mol Genet. 2023 May 5;32(10):1647-1659. doi: 10.1093/hmg/ddad004.
3
IGF-1 as a Potential Therapy for Spinocerebellar Ataxia Type 3.胰岛素样生长因子-1作为3型脊髓小脑共济失调的一种潜在治疗方法。
Biomedicines. 2022 Feb 21;10(2):505. doi: 10.3390/biomedicines10020505.
4
Deficiency of TRIM32 Impairs Motor Function and Purkinje Cells in Mid-Aged Mice.TRIM32 缺乏会损害中年小鼠的运动功能和浦肯野细胞。
Front Aging Neurosci. 2021 Aug 6;13:697494. doi: 10.3389/fnagi.2021.697494. eCollection 2021.
5
Consensus Paper: Strengths and Weaknesses of Animal Models of Spinocerebellar Ataxias and Their Clinical Implications.共识文件:脊髓小脑共济失调动物模型的优缺点及其临床意义
Cerebellum. 2022 Jun;21(3):452-481. doi: 10.1007/s12311-021-01311-1. Epub 2021 Aug 10.
6
DNAzyme Cleavage of CAG Repeat RNA in Polyglutamine Diseases.DNA 酶切割多聚谷氨酰胺疾病中的 CAG 重复 RNA。
Neurotherapeutics. 2021 Jul;18(3):1710-1728. doi: 10.1007/s13311-021-01075-w. Epub 2021 Jun 23.
7
Gene Therapy for Neurodegenerative Diseases: Slowing Down the Ticking Clock.神经退行性疾病的基因治疗:放慢生命时钟
Front Neurosci. 2020 Sep 18;14:580179. doi: 10.3389/fnins.2020.580179. eCollection 2020.
8
Generation of Common Marmoset Model Lines of Spinocerebellar Ataxia Type 3.3型脊髓小脑共济失调普通狨猴模型系的建立
Front Neurosci. 2020 Sep 24;14:548002. doi: 10.3389/fnins.2020.548002. eCollection 2020.
9
Endocannabinoid System in Spinocerebellar Ataxia Type-3 and Other Autosomal-Dominant Cerebellar Ataxias: Potential Role in Pathogenesis and Expected Relevance as Neuroprotective Targets.3型脊髓小脑共济失调及其他常染色体显性遗传性小脑共济失调中的内源性大麻素系统:在发病机制中的潜在作用及作为神经保护靶点的预期相关性
Front Mol Neurosci. 2019 Apr 24;12:94. doi: 10.3389/fnmol.2019.00094. eCollection 2019.
10
Persistent motor dysfunction despite homeostatic rescue of cerebellar morphogenesis in the Car8 waddles mutant mouse.尽管 Car8 waddles 突变体小鼠的小脑形态发生的体内平衡挽救了,但仍存在持续的运动功能障碍。
Neural Dev. 2019 Mar 12;14(1):6. doi: 10.1186/s13064-019-0130-4.

本文引用的文献

1
N-terminal ataxin-3 causes neurological symptoms with inclusions, endoplasmic reticulum stress and ribosomal dislocation.N 端ataxin-3 引起包涵体、内质网应激和核糖体脱位的神经症状。
Brain. 2011 Jul;134(Pt 7):1925-42. doi: 10.1093/brain/awr118. Epub 2011 Jun 7.
2
Machado-Joseph Disease: from first descriptions to new perspectives.马查多-约瑟夫病:从最初的描述到新视角。
Orphanet J Rare Dis. 2011 Jun 2;6:35. doi: 10.1186/1750-1172-6-35.
3
Overexpression of the autophagic beclin-1 protein clears mutant ataxin-3 and alleviates Machado-Joseph disease.自噬相关蛋白 beclin-1 的过表达可以清除突变型 ataxin-3,从而缓解 Machado-Joseph 病。
Brain. 2011 May;134(Pt 5):1400-15. doi: 10.1093/brain/awr047. Epub 2011 Apr 7.
4
Role of inositol 1,4,5-trisphosphate receptors in pathogenesis of Huntington's disease and spinocerebellar ataxias.三磷酸肌醇受体在亨廷顿病和脊髓小脑共济失调发病机制中的作用。
Neurochem Res. 2011 Jul;36(7):1186-97. doi: 10.1007/s11064-010-0393-y. Epub 2011 Jan 6.
5
HDAC inhibitor sodium butyrate reverses transcriptional downregulation and ameliorates ataxic symptoms in a transgenic mouse model of SCA3.组蛋白去乙酰化酶抑制剂丁酸钠逆转 SCA3 转基因小鼠模型中的转录下调并改善共济失调症状。
Neurobiol Dis. 2011 Feb;41(2):481-8. doi: 10.1016/j.nbd.2010.10.019. Epub 2010 Nov 1.
6
The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability.Machado-Joseph 病相关突变型 ataxin-3 调节 parkin 的泛素化和稳定性。
Hum Mol Genet. 2011 Jan 1;20(1):141-54. doi: 10.1093/hmg/ddq452. Epub 2010 Oct 11.
7
Motor uncoordination and neuropathology in a transgenic mouse model of Machado-Joseph disease lacking intranuclear inclusions and ataxin-3 cleavage products.运动不协调和神经病理学在一个缺乏核内包涵体和 ataxin-3 切割产物的 Machado-Joseph 病转基因小鼠模型中。
Neurobiol Dis. 2010 Oct;40(1):163-76. doi: 10.1016/j.nbd.2010.05.021. Epub 2010 May 25.
8
Repeat expansion disease: progress and puzzles in disease pathogenesis.重复扩展疾病:疾病发病机制的进展和难题。
Nat Rev Genet. 2010 Apr;11(4):247-58. doi: 10.1038/nrg2748.
9
Preventing Ataxin-3 protein cleavage mitigates degeneration in a Drosophila model of SCA3.防止 Ataxin-3 蛋白裂解可减轻 SCA3 的果蝇模型中的变性。
Hum Mol Genet. 2009 Dec 15;18(24):4843-52. doi: 10.1093/hmg/ddp456. Epub 2009 Sep 25.
10
A transgenic mouse model of spinocerebellar ataxia type 3 resembling late disease onset and gender-specific instability of CAG repeats.一种类似于脊髓小脑共济失调 3 型的迟发性疾病发作和 CAG 重复不稳定的性别特异性的转基因小鼠模型。
Neurobiol Dis. 2010 Feb;37(2):284-93. doi: 10.1016/j.nbd.2009.08.002. Epub 2009 Aug 20.

脊髓小脑共济失调 3 型(马查多-约瑟夫病)的小鼠模型。

Mouse models of spinocerebellar ataxia type 3 (Machado-Joseph disease).

机构信息

Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Departamento de Fisiología, Biofísica y Neurociencias, 07360 México DF, México.

出版信息

Neurotherapeutics. 2012 Apr;9(2):285-96. doi: 10.1007/s13311-012-0117-x.

DOI:10.1007/s13311-012-0117-x
PMID:22451301
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3337014/
Abstract

Machado-Joseph disease, also called spinocerebellar ataxia type 3 (MJD/SCA3), is a hereditary and neurodegenerative movement disorder caused by ataxin-3 with a pathological polyglutamine stretch (mutant ataxin-3). Seven transgenic mouse models expressing full-length human mutant ataxin-3 throughout the brain have been generated and are compared in this review. They vary in the corresponding transgenic DNA constructs with differences that include the encoded human ataxin-3 isoform(s), number of polyglutamine(s), and the promoter driving transgene expression. The behaviors/signs evaluated in most models are body weight, balance/coordination, locomotor activity, gait, limb position, and age at death. The pathology analyzed includes presence of neuronal intranuclear inclusions, and qualitative evidence of neurodegeneration. On the basis of striking similarities in age-range of detection and number of behavior/sign abnormalities and pathology, all but 1 mouse model could be readily sorted into groups with high, intermediate, and low severity of phenotype. Stereological analysis of neurodegeneration was performed in the same brain regions in 2 mouse models; the corresponding results are consistent with the classification of the mouse models.

摘要

马查多-约瑟夫病,又称脊髓小脑共济失调 3 型(MJD/SCA3),是一种遗传性和神经退行性运动障碍,由带有病理多聚谷氨酰胺延伸(突变型 ataxin-3)的 ataxin-3 引起。本综述比较了 7 种在大脑中表达全长人突变型 ataxin-3 的转基因小鼠模型。它们在相应的转基因 DNA 构建体中存在差异,包括编码的人类 ataxin-3 同工型、多聚谷氨酰胺的数量以及驱动转基因表达的启动子。大多数模型评估的行为/体征包括体重、平衡/协调、运动活性、步态、肢体位置和死亡年龄。分析的病理学包括神经元核内包涵体的存在和神经退行性变的定性证据。基于在检测范围内年龄和行为/体征异常及病理学数量的惊人相似性,除 1 种小鼠模型外,所有模型都可以很容易地分为高、中、低严重程度表型组。在 2 种小鼠模型中对相同脑区的神经退行性变进行了体视学分析;相应的结果与小鼠模型的分类一致。